Nine Ten Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TechTarget
TTGT
|
+$22.1M |
| 2 |
REIS
Reis, Inc.
REIS
|
+$2.79M |
| 3 |
Anterix
ATEX
|
+$1.2M |
| 4 |
StoneX
SNEX
|
+$817K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mesa Laboratories
MLAB
|
+$2.41M |
| 2 |
TAX
Liberty Tax, Inc. Class A
TAX
|
+$1.74M |
| 3 |
Utah Medical Products
UTMD
|
+$1.65M |
| 4 |
Omega Flex
OFLX
|
+$570K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 40.22% |
| 2 | Technology | 19.98% |
| 3 | Consumer Discretionary | 16.95% |
| 4 | Financials | 8.4% |
| 5 | Healthcare | 5.72% |
Similar funds
Nine Ten Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Nine Ten Capital Management held 10 positions worth $270M, up 3.2% from $262M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Nine Ten Capital Management deployed $20.5M of net new capital in Q2 2016, opening 1 new position and adding to 3 existing holdings. Its largest new stake was TechTarget: 2,810,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Industrials at 40% of assets, down from 44% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Mesa Laboratories, an estimated $2.41M trimmed.
- Nine Ten Capital Management's largest Q2 2016 buy was TechTarget: 2,810,000 shares worth $22.8M.
- Nine Ten Capital Management added most to Reis, Inc. in Q2 2016, an estimated $2.79M increase.
- Nine Ten Capital Management's biggest Q2 2016 reduction was Mesa Laboratories, cutting an estimated $2.41M.
- Nine Ten Capital Management's ten largest holdings make up 100% of its $270M portfolio in Q2 2016.
- Nine Ten Capital Management opened 1 new position and closed 0 in Q2 2016.
- Nine Ten Capital Management's portfolio value rose 3.2% quarter-over-quarter to $270M.
Based on Nine Ten Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.